Cargando…
Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma
Cholangiocarcinoma is a deadly cancer worldwide, associated with a poor prognosis and limited therapeutic options. Although cholangiocarcinoma accounts for less than 15% of liver primary cancer, its silent nature restricts early diagnosis and prevents efficient treatment. Therefore, it is of clinica...
Autores principales: | Papoutsoglou, Panagiotis, Louis, Corentin, Coulouarn, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770250/ https://www.ncbi.nlm.nih.gov/pubmed/31450767 http://dx.doi.org/10.3390/cells8090960 |
Ejemplares similares
-
TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p
por: Louis, Corentin, et al.
Publicado: (2023) -
The noncoding MIR100HG RNA enhances the autocrine function of transforming growth factor β signaling
por: Papoutsoglou, Panagiotis, et al.
Publicado: (2021) -
TGFβ‐induced FOXS1 controls epithelial–mesenchymal transition and predicts a poor prognosis in liver cancer
por: Bévant, Kevin, et al.
Publicado: (2021) -
Long non‐coding RNAs and TGF‐β signaling in cancer
por: Papoutsoglou, Panagiotis, et al.
Publicado: (2020) -
A novel transforming growth factor beta‐induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma
por: Merdrignac, Aude, et al.
Publicado: (2018)